Suppr超能文献

用于原位人胶质母细胞瘤模型中突变型 EGF 受体成像的 MR 信号放大。

MR signal amplification for imaging of the mutant EGF receptor in orthotopic human glioma model.

机构信息

Department of Radiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA.

出版信息

Mol Imaging Biol. 2013 Dec;15(6):675-84. doi: 10.1007/s11307-013-0653-8.

Abstract

PURPOSE

To investigate the potential of targeted MR signal amplification strategy for imaging of EGF receptor variant III (EGFRvIII) overexpression associated with the infiltrating margin of aggressive orthotopic brain tumors.

PROCEDURES

F(ab')2 fragments of humanized anti-EGFRvIII monoclonal antibody (EMD72000) were linked to deglycosylated horseradish peroxidase (HRP) and glucose oxidase (GOX). Detection of the F(ab')2 conjugate pair colocalization in vivo was enabled by a subsequent IV injection of a low molecular weight paramagnetic substrate of HRP, diTyr-GdDTPA.

RESULTS

The delivery of the targeted fragments to the tumor was validated using SPECT/CT imaging of radiolabeled anti-EGFRvIII F(ab')2 conjugates. Further, by using 3 T MRI, we observed time-dependent differences in tumor signal intensity and signal retention at the endpoint depending on whether or not the animals were pre-injected with the anti-EGFRvIII F(ab')2 conjugates.

CONCLUSIONS

Imaging of EGFRvIII expression in vivo was enabled by consecutive administration of targeted F(ab')2 conjugates and a paramagnetic substrate resulting in a tumor-specific receptor detection with high specificity and resolution.

摘要

目的

研究靶向磁共振信号放大策略在成像表皮生长因子受体变异 III(EGFRvIII)过表达中的潜力,该过表达与侵袭性原位脑肿瘤的浸润边缘有关。

过程

将人源化抗 EGFRvIII 单克隆抗体(EMD72000)的 F(ab')2 片段与去糖基化辣根过氧化物酶(HRP)和葡萄糖氧化酶(GOX)连接。通过随后静脉注射 HRP 的低分子量顺磁底物二酪氨酸-GdDTPA,实现了 F(ab')2 缀合物对体内共定位的检测。

结果

使用放射性标记的抗 EGFRvIII F(ab')2 缀合物的 SPECT/CT 成像验证了靶向片段向肿瘤的递呈。此外,通过使用 3T MRI,我们观察到根据动物是否预先注射抗 EGFRvIII F(ab')2 缀合物,肿瘤信号强度和终点处的信号保留存在时间依赖性差异。

结论

通过连续给予靶向 F(ab')2 缀合物和顺磁底物,实现了体内 EGFRvIII 表达的成像,从而具有高特异性和分辨率的肿瘤特异性受体检测。

相似文献

1
MR signal amplification for imaging of the mutant EGF receptor in orthotopic human glioma model.
Mol Imaging Biol. 2013 Dec;15(6):675-84. doi: 10.1007/s11307-013-0653-8.
2
Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
Cancer Res. 2011 Mar 15;71(6):2230-9. doi: 10.1158/0008-5472.CAN-10-1139. Epub 2011 Jan 18.
5
Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.
Radiology. 2013 Apr;267(1):173-82. doi: 10.1148/radiol.12121021. Epub 2013 Jan 17.
7
Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model.
Radiol Imaging Cancer. 2021 Jul;3(4):e200069. doi: 10.1148/rycan.2021200069.

引用本文的文献

1
Miniaturized Fab' imaging probe derived from a clinical antibody: Characterization and imaging in CRISPRi-attenuated mammary tumor models.
iScience. 2024 May 24;27(8):110102. doi: 10.1016/j.isci.2024.110102. eCollection 2024 Aug 16.
2
Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model.
Radiol Imaging Cancer. 2021 Jul;3(4):e200069. doi: 10.1148/rycan.2021200069.

本文引用的文献

1
Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?
Adv Exp Med Biol. 2013;779:267-89. doi: 10.1007/978-1-4614-6176-0_12.
2
Pretargeted molecular imaging and radioimmunotherapy.
Theranostics. 2012;2(5):523-40. doi: 10.7150/thno.3582. Epub 2012 May 17.
3
Individualized targeted therapy for glioblastoma: fact or fiction?
Cancer J. 2012 Jan-Feb;18(1):40-4. doi: 10.1097/PPO.0b013e318243f6c9.
4
Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15984-9. doi: 10.1073/pnas.1113416108. Epub 2011 Sep 6.
7
Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
Cancer Res. 2011 Mar 15;71(6):2230-9. doi: 10.1158/0008-5472.CAN-10-1139. Epub 2011 Jan 18.
9
Spatial control of EGF receptor activation by reversible dimerization on living cells.
Nature. 2010 Apr 1;464(7289):783-7. doi: 10.1038/nature08827. Epub 2010 Mar 7.
10
Panitumumab: in metastatic colorectal cancer with wild-type KRAS.
BioDrugs. 2008;22(6):403-11. doi: 10.2165/0063030-200822060-00006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验